Annual Net Income
-$35.33 M
-$21.09 M-148.16%
31 December 2023
Summary:
Co-Diagnostics annual net profit is currently -$35.33 million, with the most recent change of -$21.09 million (-148.16%) on 31 December 2023. During the last 3 years, it has fallen by -$77.81 million (-183.18%). CODX annual net income is now -183.18% below its all-time high of $42.48 million, reached on 31 December 2020.CODX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$9.70 M
-$2.10 M-27.60%
30 September 2024
Summary:
Co-Diagnostics quarterly net profit is currently -$9.70 million, with the most recent change of -$2.10 million (-27.60%) on 30 September 2024. Over the past year, it has dropped by -$3.71 million (-62.09%). CODX quarterly net income is now -161.64% below its all-time high of $15.73 million, reached on 30 September 2020.CODX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$41.28 M
-$3.71 M-9.89%
30 September 2024
Summary:
Co-Diagnostics TTM net profit is currently -$41.28 million, with the most recent change of -$3.71 million (-9.89%) on 30 September 2024. Over the past year, it has increased by +$1.28 million (+3.00%). CODX TTM net income is now -180.25% below its all-time high of $51.44 million, reached on 31 March 2021.CODX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CODX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -148.2% | -62.1% | +3.0% |
| 3 y3 years | -183.2% | -184.5% | -198.4% |
| 5 y5 years | -463.4% | -454.8% | -544.2% |
CODX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -183.2% | at low | -182.8% | +55.7% | -198.4% | +3.0% |
| 5 y | 5 years | -183.2% | at low | -161.6% | +55.7% | -180.3% | +3.0% |
| alltime | all time | -183.2% | at low | -161.6% | +55.7% | -180.3% | +3.0% |
Co-Diagnostics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.70 M(+27.6%) | -$41.28 M(+9.9%) |
| June 2024 | - | -$7.60 M(-18.4%) | -$37.57 M(-3.4%) |
| Mar 2024 | - | -$9.31 M(-36.6%) | -$38.89 M(+10.1%) |
| Dec 2023 | -$35.33 M(+148.2%) | -$14.68 M(+145.3%) | -$35.33 M(-17.0%) |
| Sept 2023 | - | -$5.98 M(-32.9%) | -$42.56 M(+12.2%) |
| June 2023 | - | -$8.92 M(+55.0%) | -$37.94 M(+19.7%) |
| Mar 2023 | - | -$5.76 M(-73.7%) | -$31.71 M(+122.7%) |
| Dec 2022 | -$14.24 M(-138.8%) | -$21.91 M(+1509.4%) | -$14.24 M(-193.9%) |
| Sept 2022 | - | -$1.36 M(-49.3%) | $15.17 M(-45.8%) |
| June 2022 | - | -$2.69 M(-122.9%) | $28.00 M(-30.8%) |
| Mar 2022 | - | $11.71 M(+56.2%) | $40.47 M(+10.4%) |
| Dec 2021 | $36.66 M(-13.7%) | $7.50 M(-34.7%) | $36.66 M(-12.6%) |
| Sept 2021 | - | $11.48 M(+17.3%) | $41.97 M(-9.2%) |
| June 2021 | - | $9.79 M(+23.9%) | $46.22 M(-10.1%) |
| Mar 2021 | - | $7.90 M(-38.3%) | $51.44 M(+21.1%) |
| Dec 2020 | $42.48 M | $12.81 M(-18.6%) | $42.48 M(+52.1%) |
| Sept 2020 | - | $15.73 M(+4.8%) | $27.94 M(+167.2%) |
| June 2020 | - | $15.01 M(-1508.7%) | $10.46 M(-277.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$1.07 M(-38.6%) | -$5.89 M(-4.9%) |
| Dec 2019 | -$6.20 M(-1.2%) | -$1.74 M(-0.7%) | -$6.20 M(-3.3%) |
| Sept 2019 | - | -$1.75 M(+30.0%) | -$6.41 M(+1.7%) |
| June 2019 | - | -$1.34 M(-1.8%) | -$6.30 M(-0.4%) |
| Mar 2019 | - | -$1.37 M(-29.8%) | -$6.33 M(+0.9%) |
| Dec 2018 | -$6.27 M(-9.9%) | -$1.95 M(+18.7%) | -$6.27 M(+7.6%) |
| Sept 2018 | - | -$1.64 M(+19.6%) | -$5.83 M(-27.9%) |
| June 2018 | - | -$1.37 M(+4.7%) | -$8.08 M(+6.8%) |
| Mar 2018 | - | -$1.31 M(-12.9%) | -$7.56 M(+8.7%) |
| Dec 2017 | -$6.96 M(+260.8%) | -$1.50 M(-61.3%) | -$6.96 M(+16.4%) |
| Sept 2017 | - | -$3.89 M(+355.4%) | -$5.98 M(+135.8%) |
| June 2017 | - | -$855.00 K(+21.2%) | -$2.54 M(+19.4%) |
| Mar 2017 | - | -$705.70 K(+34.4%) | -$2.12 M(-38.6%) |
| Dec 2016 | -$1.93 M(-5.6%) | -$525.20 K(+16.7%) | -$3.46 M(+17.9%) |
| Sept 2016 | - | -$450.00 K(+1.7%) | -$2.94 M(+18.1%) |
| June 2016 | - | -$442.60 K(-78.3%) | -$2.49 M(+21.7%) |
| Mar 2016 | - | -$2.04 M | -$2.04 M |
| Dec 2015 | -$2.04 M | - | - |
FAQ
- What is Co-Diagnostics annual net profit?
- What is the all time high annual net income for Co-Diagnostics?
- What is Co-Diagnostics annual net income year-on-year change?
- What is Co-Diagnostics quarterly net profit?
- What is the all time high quarterly net income for Co-Diagnostics?
- What is Co-Diagnostics quarterly net income year-on-year change?
- What is Co-Diagnostics TTM net profit?
- What is the all time high TTM net income for Co-Diagnostics?
- What is Co-Diagnostics TTM net income year-on-year change?
What is Co-Diagnostics annual net profit?
The current annual net income of CODX is -$35.33 M
What is the all time high annual net income for Co-Diagnostics?
Co-Diagnostics all-time high annual net profit is $42.48 M
What is Co-Diagnostics annual net income year-on-year change?
Over the past year, CODX annual net profit has changed by -$21.09 M (-148.16%)
What is Co-Diagnostics quarterly net profit?
The current quarterly net income of CODX is -$9.70 M
What is the all time high quarterly net income for Co-Diagnostics?
Co-Diagnostics all-time high quarterly net profit is $15.73 M
What is Co-Diagnostics quarterly net income year-on-year change?
Over the past year, CODX quarterly net profit has changed by -$3.71 M (-62.09%)
What is Co-Diagnostics TTM net profit?
The current TTM net income of CODX is -$41.28 M
What is the all time high TTM net income for Co-Diagnostics?
Co-Diagnostics all-time high TTM net profit is $51.44 M
What is Co-Diagnostics TTM net income year-on-year change?
Over the past year, CODX TTM net profit has changed by +$1.28 M (+3.00%)